Role of aromatic L-amino acid decarboxylase for dopamine replacement by genetically modified fibroblasts in a rat model of Parkinson's disease

Journal of Neurochemistry

Volumn 69, Issue 5, 1997, Pages 2055-2063

  Wachtel, Stephen R ^a   Bencsics, Craig ^a,b   Kang, Un Jung ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dopamine; GTP cyclohydrolase I; L DOPA; Microdiaiysis; Striatum; Tyrosine hydroxylase

Indexed keywords

AROMATIC LEVO AMINO ACID DECARBOXYLASE; CATECHOLAMINE; DOPAMINE; GUANOSINE TRIPHOSPHATE CYCLOHYDROLASE I; LEVODOPA; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATECHOLAMINE SYNTHESIS; CONTROLLED STUDY; CORPUS STRIATUM; FEMALE; FIBROBLAST; GENE TRANSFER; GENETIC ENGINEERING; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0030777372     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69052055.x     Document Type: Article

References (48)

1. Abercrombie E. D., Bonatz A. E., and Zigmond M. J. (1990) Effects of L-DOPA on extracellular dopamine in striatum of normal and 6-hydroxydopamine-treated rats. Brain Res. 525, 36-44.
2. Arai R., Karasawa N., Geffard M., Nagatsu T., and Nagatsu I. (1994) Immunohistochemical evidence that central serotonin neurons produce dopamine from exogenous L-DOPA in the rat, with reference to the involvement of aromatic L-amino acid decarboxylase. Brain Res. 667, 295-299.
3. Arai R., Karasawa N., Geffard M., and Nagatsu I. (1995) L-DOPA is converted to dopamine in serotonergic fibers of the striatum of the rat: a double-labeling immunofluorescence study. Neurosci. Lett. 195, 195-198.
4. Arai R., Karasawa N., and Nagatsu I. (1996) Aromatic L-amino acid decarboxylase is present in serotonergic fibers of the striatum of the rat. A double-labeling immunofluorescence study. Brain Res. 706, 177-179.
5. Bencsics C., Wachtel S. R., Milstien S., Hatakeyama K., Becker J. B., and Kang U. J. (1996) Double transduction with GTP cyclohydrolase I and tyrosine hydroxylase is necessary for spontaneous synthesis of L-DOPA by primary fibroblasts. J. Neurosci. 16, 4449-4456.
6. Burke W. J. and Joh T. H. (1988) Effect of dopamine on tyrosine hydroxylase in cultured rat adrenal medulla. Biochem. Pharmacol. 37, 1391-1397.
7. Daubner S. C. and Piper M. M. (1995) Deletion mutants of tyrosine hydroxylase identify a region critical for heparin binding. Protein Sci. 4, 538-541.
8. Daubner S. C., Lauriano C., Haycock J. W., and Fitzpatrick P. F. (1992) Site-directed mutagenesis of serine 40 of rat tyrosine hydroxylase. J. Biol. Chem. 267, 12639-12646.
9. During M. J., Naegle J. R., O'Malley K. L., and Geller A. I. (1994) Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266, 1399-1403.
10. Fisher L.J. Jinnah H. A., Kale L. C., Higgins G. A., and Gage F. H. (1991) Survival and function of intrastriatally grafted primary fibroblasts genetically modified to produce L-DOPA. Neuron 6, 371-380.
11. Goldstein M. (1995) Long- and short-term regulation of tyrosine hydroxylase, in Pscyhopharmacology: The Fourth Generation of Progress (Bloom F. E. and Kupfer D. J., eds), pp. 189-195. Raven Press. New York.
12. Harada K., Wu J., Haycock J. W., and Goldstein M. (1996) Regulation of L-DOPA biosynthesis by site-specific phosphorylation of tyrosine hydroxylase in AtT-20 cells expressing wild-type and serine 40-substituted enzyme. J. Neurochem. 67, 629-635.
13. Hefti F., Melamed E., and Wurtman R. J. (1981) The site of dopamine formation in rat striatum after L-DOPA administration. J. Pharmacol. Exp. Ther. 217, 189-197.
14. Horellou P., Guibert B., Leviel V., and Mallet J. (1989) Retroviral transfer of a human tyrosine hydroxylase cDNA in various cell lines: regulated release of dopamine in mouse anterior pituitary AtT-20 cells. Proc. Natl Acad. Sci. USA 86, 7233-7237.
15. Horellou P., Brundin P., Kalen P., Mallet J., and Björklund A. (1990) In vivo release of DOPA and dopamine from genetically engineered cells grafted to the denervated rat striatum. Neuron 5, 393-402.
16. Juorio A. V., Li X.-M., Walz W., and Paterson I. A. (1993) Decarboxylation of L-Dopa by cultured mouse astrocytes. Brain Res. 626, 306-309.
17. Kang U. J., Park D. H., Wessel T., Baker H., and Joh T. H. (1992) DOPA-decarboxylation in the striata of rats with unilateral substantia nigra lesions. Neurosci. Lett. 147, 53-57.
18. Kang U. J., Fisher L. J., Joh T. H., O'Malley K. L., and Gage F. H. (1993) Regulation of dopamine production by genetically modified primary fibroblasts. J. Neurosci. 13, 5203-5211.
19. Kaplitt M. G. and During M. J. (1995) Transfer and expression of potentially therapeutic genes into the mammalian central nervous system in vivo using adeno-assodated viral vectors, in Viral Vectors: Gene Therapy and Neuroscience Applications (Kaplitt M. G. and Loewy A. D., eds), pp. 193-210. Academic Press, San Diego.
20. Kawaja M. D., Rosenberg M. B., Yoshida K., and Gage F. H. (1992) Somatic gene transfer of nerve growth factor promotes the survival of axotomized septal neurons and regeneration of their axons in adull rats. J. Neurosci. 12, 2849-2864.
21. Kumer S. C. and Vrana K. E. (1996) Intricate regulation of tyrosine hydroxylase activity and gene expression. J. Neurochem. 67, 443-462.
22. Laschinski G., Kittner B., and Brautigam M. (1984) Inhibition of striatal tyrosine hydroxylase by low concentrations of apomorphine. Naunyn Schmiedebergs Arch. Pharmacol. 327, 114-118.
23. Laschinski G., Kittner B., and Brautigam M. (1986) Direct inhibition of tyrosine hydroxylase from PC-12 cells by catechol derivatives. Naunyn Schmiedebergs Arch. Pharmacol. 332, 346-350.
24. Levine R. A., Miller L. P., and Lovenberg W. (1981) Tetrahydrobiopterin in striatum: localization in dopamine nerve terminals and role in catecholamine synthesis. Science 213, 349-350.
25. Levivier M., Przedborski S., Bencsics C., and Kang U. J. (1995) Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of Parkinson's disease. J. Neurosci. 15, 7810-7820.
26. Li X.-M., Juorio A. V., Paterson I. A., Walz W., Zhu M-Y., and Boulton A. A. (1992) Gene expression of aromatic L-amino acid decarboxylase in cultured rat glial cells. J. Neurochem. 59, 1172-1175.
27. Lucidi-Phillipi C. A., Gage F. H., Shults C. W., Jones K. R., Reichardt L. F., and Kang U. J. (1995) BDNF-transduced fibroblasts: production of BDNF and effects of grafting to the adult rat brain. J. Comp. Neurol 354, 361-376.
28. Marsden C. D. and Parkes J. D. (1977) Success and problems of long-term levodopa therapy in Parkinson's disease. Lancet 1, 345-349.
29. Melamed E., Hefti F., Liebman J., Schlosberg A. J., and Wurtman R. J. (1980) Serotonergic neurons are not involved in action of L-DOPA in Parkinson's disease. Nature 283, 772-774.
30. Melamed E., Hefti F., Pettibone D. J., Liebman J., and Wurtman R. J. (1981) Aromatic L-amino acid decarboxylase in rat corpus striatum: implications for action of L-DOPA in parkinsonism. Neurology 31, 651-655.
31. Mouradian M. M., Heuser I. J., Baronti F., and Chase T. N. (1990) Modification of central dopaminergic mechanisms by continuous levodopa therapy for advanced Parkinson's disease. Ann. Neurol. 27, 18-23.
32. Mura A., Jackson D., Manley M. S., Young S. J., and Groves P. M. (1995) Aromatic L-amino acid decarboxylase immunoreactive cells in the rat striatum: a possible site for the conversion of exogenous L-DOPA to dopamine. Brain Res. 704, 51-60.
33. Nagatsu T., Levitt M., and Udenfriend S. (1964a) Tyrosine hydroxylase: the initial step in norepinephrine synthesis. J. Biol. Chem. 239, 2910-2917.
34. Nagatsu T., Levitt M., and Udenfriend S. (1964b) A rapid and simple radioassay for tyrosine hydroxylase activity. Anal. Biochem. 9, 122-126.
35. Ng L. K. Y., Chase T. N., Colburn R. W., and Kopin I. J. (1972) L-Dopa in parkinsonism: a possible mechanism of action. Neurology 22, 688-696.
36. Paxinos G. and Watson C. (1986) The Rut Brain in Slereotaxic Coordinates. Academic Press, San Diego.
37. Quinn N., Marsden C. D., and Parkes J. D. (1982) Complicated response fluctuations in Parkinson's disease: response to intravenous infusion of levodopa. Lancet 2, 412-415.
38. 3H]-tyrosine by charcoal. Life Sci. 39, 2185-2189.
39. Ribeiro P., Wang Y., Citron B. A., and Kaufman S. (1992) Regulation of recombinant rat tyrosine hydroxylase by dopamine. Proc. Natl. Acad. Sci. USA 89, 9593-9597.
40. Ribeiro P., Wang Y., Citron B. A., and Kaufman S. (1993) Deletion mutagenesis of rat PC12 tyrosine hydroxylase regulatory and catalytic domains. J. Mol. Neurosci. 4, 125-139.
41. Shoulson I., Glaubiger G. A., and Chase T. N. (1975) On-off response. Clinical and biochemical correlations during oral and intravenous levodopa administration in parkinsonian patients. Neurology 25, 1144-1148.
42. Stocchi F., Ruggieri S., Brughitta G., and Agnoli A. (1986) Problems in daily motor performances in Parkinson's disease: the continuous dopaminergic stimulation. J. Neural Transm. 22(Suppl.), 209-218.
43. Tashiro T., Kaneko T., Sugimoto T., Nagatsu I., Kikuchi H., and Mizuno N. (1989) Striatal neurons with aromatic L-amino acid decarboxylase-like immunoreactivity in the rat. Neurosci. Lett. 100, 29-34.
44. Tison F., Normand E., Jaber M., Aubert I., and Bloch B. (1991) Aromatic L-amino-acid decarboxylase (DOPA decarboxylase) gene expression in dopaminergic and serotonergic cells of the rat brainstem. Neurosci. Lett. 127, 203-206.
45. Uchida K., Tsuzaki N., Nagatsu T., and Kohsaka S. (1992) Tetrahydrobiopterin-dependent functional recovery in 6-hydroxydopamine-treated rats by intracerebral grafting of tibroblasts transfected with tyrosine hydroxylase cDNA. Dev. Neurosci. 14, 173-180.
46. Van Horne C. Hoffer B. J., Strömberg I., and Gerhardt G. A. (1992) Clearance and diffusion of locally applied dopamine in normal and 6-hydroxydopamine-lesioned rat striatum. J. Pharmacol. Exp. Ther. 263, 1285-1292.
47. Wachtel S. R. and Abercrombie E. D. (1994) L-3,4-Dihydroxyphenylalanine-induced dopamine release in the striatum of intact and 6-hydroxydopamine-treated rats: differential effects of monoamine oxidase A and B inhibitors. J. Neurochem. 63, 108-117.
48. Wightman R. M. and Zimmerman J. B. (1990) Control of dopamine extracellular concentration in rat striatum by impulse flow and uptake. Brain Res. Rev. 15, 135-144.